Effect of recombinant human fibronectin polypeptide CH50 on growth and metastasis of melanoma

Citation
Q. Fan et al., Effect of recombinant human fibronectin polypeptide CH50 on growth and metastasis of melanoma, ACT PHAR SI, 20(2), 1999, pp. 175-178
Citations number
7
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ACTA PHARMACOLOGICA SINICA
ISSN journal
02539756 → ACNP
Volume
20
Issue
2
Year of publication
1999
Pages
175 - 178
Database
ISI
SICI code
0253-9756(199902)20:2<175:EORHFP>2.0.ZU;2-1
Abstract
AIM: To study the effect of recombinant human fibronectin polypeptide CH50 on murine melanoma growth and metastasis, and its antitumor mechanism. METH ODS: Mouse and melanoma B16 cell, tests were used to observe antitumor effe ct and mechanism of CH50. RESULTS: CH50 markedly inhibited melanoma growth and experimental lung metastasis. The melanoma weight was reduced from (2.3 +/- 1.2) g of control group to (0.7 +/- 0.8) g of test group (P < 0.05). C H50 at 0.125, 0.25, 0.5 mg/mouse reduced melanoma lung metastatic colonies from 87 +/- 49 of control group to 34 +/- 6, 14 +/- 12, 4 +/- 2, respective ly. CH50 adhered to melanoma B16 cells and inhibited adhesion of B16 cells to laminin. CH50 enhanced the cytotoxicity of macrophages to melanoma B16 c ells. CONCLUSION: CH50 inhibited tumor growth and metastasis of murine mela noma. The antitumor effect of CH50 is related to its adhesion ability to me lanoma B16 cells and enhancing macrophage cytotoxicity.